<p>Laboratory Co. of America（纽约证券交易所：LH - 获取免费报告）的股价目标在上周五发布的一份报告中被罗伯特·W·贝尔德的股票研究分析师从 278.00 美元上调至 282.00 美元。该公司目前对这家医疗研究公司的股票给予 “表现优异” 评级。罗伯特·W·贝尔德的目标价格表明，相对于公司当前股价，潜在上涨幅度为 25.56%。</p>
<ul>
<li>航空航天股票实现强劲的盈利超预期并提高了业绩预期</li>
</ul>
<p>其他研究分析师最近也发布了有关该股票的报告。德意志银行将 Laboratory Co. of America 的股票价格目标从 220.00 美元上调至 230.00 美元，并在 8 月 2 日星期五的一份研究报告中给予该股票 “持有” 评级。摩根大通将 Laboratory Co. of America 的股票价格目标从 261.00 美元下调至 243.00 美元，并在 5 月 30 日星期四的一份研究报告中给予该股票 “超配” 评级。Evercore ISI 将 Laboratory Co. of America 的目标股价从 210.00 美元上调至 215.00 美元，并在 7 月 9 日星期二的一份研究报告中给予该股票 “持平” 评级。Truist Financial 将 Laboratory Co. of America 的目标股价从 255.00 美元上调至 275.00 美元，并在 8 月 2 日星期五的一份研究报告中给予该公司 “买入” 评级。最后，美国银行将 Laboratory Co. of America 的股票价格目标从 240.00 美元上调至 260.00 美元，并在 8 月 5 日星期一的一份报告中给予该股票 “买入” 评级。三位研究分析师对该股票给予持有评级，十位分析师给予买入评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “中度买入”，平均目标价格为 251.27 美元。</p>
<p><strong>阅读我们关于 LH 的最新股票报告</strong></p>
<h2>Laboratory Co. of America 股票表现</h2>
<ul>
<li>这家远程医疗股票在最近的回调后值得买入吗？</li>
</ul>
<p>纽约证券交易所 LH 在上周五开盘价为 224.59 美元。该公司的 50 天简单移动平均线为 222.42 美元，其两百天简单移动平均线为 211.55 美元。该公司的资产负债比为 0.39，流动比率为 0.88，速动比率为 0.77。Laboratory Co. of America 的一年最低价为 191.97 美元，一年最高价为 238.46 美元。该股市值为 189.3 亿美元，市盈率为 45.19，市盈增长比率为 1.68，贝塔系数为 1.06。</p>
<p>Laboratory Co. of America（纽约证券交易所：LH - 获取免费报告）上次公布季度财报是在 8 月 1 日星期四。这家医疗研究公司报告称，该季度每股收益为 3.94 美元，超过了 3.78 美元的共识预期 0.16 美元。该公司在该季度的营收为 32.2 亿美元，而分析师预计为 31.9 亿美元。Laboratory Co. of America 的净资产收益率为 15.39%，净利润率为 3.60%。该公司当季营收同比增长了 6.2%。去年同期，该公司每股收益为 3.42 美元。分析师预测，Laboratory Co. of America 本财年每股盈利将达到 14.67 美元。</p>
<h2>内部人士的投资</h2>
<ul>
<li>3M 股票：现在投资，享受无与伦比的质量和增长潜力</li>
</ul>
<p>相关消息称，首席财务官格伦·A·艾森伯格于 8 月 15 日星期四以每股 223.99 美元的均价出售了 15,000 股 Laboratory Co. of America 股票，总价值为 3,359,850.00 美元。此次交易后，首席财务官在公司中持有 31,289 股股票，价值 7,008,423.11 美元。该交易已在提交给美国证券交易委员会的文件中披露，可通过此超链接访问。此外，Laboratory Co. of America 首席财务官格伦·A·艾森伯格于 8 月 15 日星期四进行了另一笔交易，出售了 15,000 股 Laboratory Co. of America 股票，均价为 223.99 美元，总价值为 3,359,850.00 美元。此次交易后，首席财务官直接持有公司 31,289 股股票，价值约 7,008,423.11 美元。该交易已在提交给美国证券交易委员会的法律文件中披露，可通过此超链接访问。此外，董事凯丽·B·安德森于 8 月 8 日星期四出售了 586 股股票。该股票的均价为 225.00 美元，总价值为 131,850.00 美元。此次交易完成后，该董事直接持有公司 14,722 股股票，价值约 3,312,450 美元。此次交易的披露信息可在此处找到。过去 90 天内，内部人士共出售了 29,679 股公司股票，价值 6,716,306 美元。目前，公司股份的 0.85% 由内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者最近调整了他们对该公司的持股。Sanctuary Advisors LLC 在第二季度购入了 Laboratory Co. of America 的新股份，价值约 2,268,000 美元。Delphi Management Inc. MA 在第二季度将其对 Laboratory Co. of America 的持股增加了 134.9%。Delphi Management Inc. MA 现在拥有 8,246 股该医疗研究公司的股票，价值 1,678,000 美元，较上一季度增加了 4,736 股。3Chopt Investment Partners LLC 在第二季度购入了 Laboratory Co. of America 的新股份，价值 1,318,000 美元。EP Wealth Advisors LLC 在第二季度增加了其对 Laboratory Co. of America 的持股，增幅为 27.0%。EP Wealth Advisors LLC 现在拥有 1,226 股该医疗研究公司的股票，价值 250,000 美元，较上一季度增加了 261 股。最后，Brandes Investment Partners LP 在第二季度增加了其对 Laboratory Co. of America 的持股，增幅为 25.3%。Brandes Investment Partners LP 现在拥有 494,068 股该医疗研究公司的股票，价值 100,609,000 美元，较上一季度增加了 99,912 股。目前，公司股份的 95.94% 由机构投资者持有。</p>
<h2>美国实验室公司简介（获取免费报告）</h2>
<p>美国实验室公司是一家生命科学公司，为医生、医院、制药公司、研究人员和患者提供重要信息，帮助他们做出明晰自信的决策。公司分为实验室公司诊断（Dx）和生物制药实验室服务（BLS）两个部分运营。</p>
<h2>参见</h2>
<ul>
<li>我们喜欢的五支股票，胜过美国实验室公司</li>
<li>什么是股息王？</li>
<li>三重巫术：市场的季度过山车</li>
<li>3 家证明仍然必不可少的杂货股</li>
<li>4 支将受益于最近降息的股票</li>
<li>投资黄金股的方法和原因</li>
<li>Autohome 的股息和回购使其成为强劲的电动汽车投资</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxI?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxI"/></p>
<p><em>这则即时新闻警报是由市场数据和 MarketBeat 的叙事科技生成，旨在为读者提供最快速、最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<p>→ Nvidia 的新潜在合作伙伴是谁？（来自 Weiss Ratings）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NjMy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NjMy"/></p>
<h2>现在是否值得投资美国实验室公司 1,000 美元？</h2>
<p>在考虑投资美国实验室公司之前，您需要听到这个消息。</p>
<p>MarketBeat 追踪华尔街评级最高、表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已经确定了五支顶级分析师悄悄告诉客户现在购买的股票清单...而美国实验室公司不在其中。</p>
<p>虽然美国实验室公司目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

实验美控

<p>罗伯特·W·贝尔德（Robert W. Baird）将实验室公司（Laboratory Co. of America，NYSE:LH）的目标股价从未指定的金额上调至另一个未指定的金额，并维持 “表现优异” 评级。新的目标股价表明潜在上涨幅度为 25.56%。其他分析师也调整了他们的评级，其中三家持有评级，十家给出买入评级。该股目前有一个 “中等买入” 的共识评级，平均目标股价为未指定的金额。该公司报告的每股收益为 2.94 美元，超出预期，并且营收同比增长了 6.2%</p>

<p>Laboratory Co. of America (NYSE:LH - Get Free Report) had its price objective increased by equities research analysts at Robert W. Baird from $278.00 to $282.00 in a report released on Friday, Benzinga reports. The firm presently has an &#34;outperform&#34; rating on the medical research company's stock. Robert W. Baird's target price points to a potential upside of 25.56% from the company's current price.</p>
<ul>
<li>Aerospace Stock Fires Up a Solid EPS Beat and Raises Guidance</li>
</ul>
<div class="lb-trans"><p>Laboratory Co. of America（纽约证券交易所：LH - 获取免费报告）的股价目标在上周五发布的一份报告中被罗伯特·W·贝尔德的股票研究分析师从 278.00 美元上调至 282.00 美元。该公司目前对这家医疗研究公司的股票给予 “表现优异” 评级。罗伯特·W·贝尔德的目标价格表明，相对于公司当前股价，潜在上涨幅度为 25.56%。</p>
<ul>
<li>航空航天股票实现强劲的盈利超预期并提高了业绩预期</li>
</ul>
</div><p>Other research analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Laboratory Co. of America from $220.00 to $230.00 and gave the stock a &#34;hold&#34; rating in a research report on Friday, August 2nd. JPMorgan Chase &amp; Co. lowered their price objective on shares of Laboratory Co. of America from $261.00 to $243.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday, May 30th. Evercore ISI upped their target price on shares of Laboratory Co. of America from $210.00 to $215.00 and gave the stock an &#34;in-line&#34; rating in a research report on Tuesday, July 9th. Truist Financial raised their price target on Laboratory Co. of America from $255.00 to $275.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, August 2nd. Finally, Bank of America upped their price objective on Laboratory Co. of America from $240.00 to $260.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, August 5th. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $251.27.</p>
<div class="lb-trans"><p>其他研究分析师最近也发布了有关该股票的报告。德意志银行将 Laboratory Co. of America 的股票价格目标从 220.00 美元上调至 230.00 美元，并在 8 月 2 日星期五的一份研究报告中给予该股票 “持有” 评级。摩根大通将 Laboratory Co. of America 的股票价格目标从 261.00 美元下调至 243.00 美元，并在 5 月 30 日星期四的一份研究报告中给予该股票 “超配” 评级。Evercore ISI 将 Laboratory Co. of America 的目标股价从 210.00 美元上调至 215.00 美元，并在 7 月 9 日星期二的一份研究报告中给予该股票 “持平” 评级。Truist Financial 将 Laboratory Co. of America 的目标股价从 255.00 美元上调至 275.00 美元，并在 8 月 2 日星期五的一份研究报告中给予该公司 “买入” 评级。最后，美国银行将 Laboratory Co. of America 的股票价格目标从 240.00 美元上调至 260.00 美元，并在 8 月 5 日星期一的一份报告中给予该股票 “买入” 评级。三位研究分析师对该股票给予持有评级，十位分析师给予买入评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “中度买入”，平均目标价格为 251.27 美元。</p>
</div><p><strong>Read Our Latest Stock Report on LH</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 LH 的最新股票报告</strong></p>
</div><h2>Laboratory Co. of America Stock Performance</h2>
<ul>
<li>Is This Telehealth Stock a Buy After the Recent Pullback?</li>
</ul>
<div class="lb-trans"><h2>Laboratory Co. of America 股票表现</h2>
<ul>
<li>这家远程医疗股票在最近的回调后值得买入吗？</li>
</ul>
</div><p>NYSE LH opened at $224.59 on Friday. The company's 50 day simple moving average is $222.42 and its two-hundred day simple moving average is $211.55. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.88 and a quick ratio of 0.77. Laboratory Co. of America has a 1 year low of $191.97 and a 1 year high of $238.46. The stock has a market capitalization of $18.93 billion, a PE ratio of 45.19, a P/E/G ratio of 1.68 and a beta of 1.06.</p>
<div class="lb-trans"><p>纽约证券交易所 LH 在上周五开盘价为 224.59 美元。该公司的 50 天简单移动平均线为 222.42 美元，其两百天简单移动平均线为 211.55 美元。该公司的资产负债比为 0.39，流动比率为 0.88，速动比率为 0.77。Laboratory Co. of America 的一年最低价为 191.97 美元，一年最高价为 238.46 美元。该股市值为 189.3 亿美元，市盈率为 45.19，市盈增长比率为 1.68，贝塔系数为 1.06。</p>
</div><p>Laboratory Co. of America (NYSE:LH - Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The medical research company reported $3.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.78 by $0.16. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.19 billion. Laboratory Co. of America had a return on equity of 15.39% and a net margin of 3.60%. The firm's quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company earned $3.42 earnings per share. Analysts predict that Laboratory Co. of America will post 14.67 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Laboratory Co. of America（纽约证券交易所：LH - 获取免费报告）上次公布季度财报是在 8 月 1 日星期四。这家医疗研究公司报告称，该季度每股收益为 3.94 美元，超过了 3.78 美元的共识预期 0.16 美元。该公司在该季度的营收为 32.2 亿美元，而分析师预计为 31.9 亿美元。Laboratory Co. of America 的净资产收益率为 15.39%，净利润率为 3.60%。该公司当季营收同比增长了 6.2%。去年同期，该公司每股收益为 3.42 美元。分析师预测，Laboratory Co. of America 本财年每股盈利将达到 14.67 美元。</p>
</div><h2>Insiders Place Their Bets</h2>
<ul>
<li>3M Stock: Invest Now for Unmatched Quality and Growth Potential</li>
</ul>
<div class="lb-trans"><h2>内部人士的投资</h2>
<ul>
<li>3M 股票：现在投资，享受无与伦比的质量和增长潜力</li>
</ul>
</div><p>In related news, CFO Glenn A. Eisenberg sold 15,000 shares of Laboratory Co. of America stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $223.99, for a total value of $3,359,850.00. Following the sale, the chief financial officer now owns 31,289 shares in the company, valued at $7,008,423.11. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Laboratory Co. of America news, CFO Glenn A. Eisenberg sold 15,000 shares of Laboratory Co. of America stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $223.99, for a total transaction of $3,359,850.00. Following the sale, the chief financial officer now directly owns 31,289 shares of the company's stock, valued at approximately $7,008,423.11. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kerrii B. Anderson sold 586 shares of the stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $225.00, for a total value of $131,850.00. Following the completion of the transaction, the director now directly owns 14,722 shares of the company's stock, valued at approximately $3,312,450. The disclosure for this sale can be found here. In the last 90 days, insiders sold 29,679 shares of company stock worth $6,716,306. 0.85% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>相关消息称，首席财务官格伦·A·艾森伯格于 8 月 15 日星期四以每股 223.99 美元的均价出售了 15,000 股 Laboratory Co. of America 股票，总价值为 3,359,850.00 美元。此次交易后，首席财务官在公司中持有 31,289 股股票，价值 7,008,423.11 美元。该交易已在提交给美国证券交易委员会的文件中披露，可通过此超链接访问。此外，Laboratory Co. of America 首席财务官格伦·A·艾森伯格于 8 月 15 日星期四进行了另一笔交易，出售了 15,000 股 Laboratory Co. of America 股票，均价为 223.99 美元，总价值为 3,359,850.00 美元。此次交易后，首席财务官直接持有公司 31,289 股股票，价值约 7,008,423.11 美元。该交易已在提交给美国证券交易委员会的法律文件中披露，可通过此超链接访问。此外，董事凯丽·B·安德森于 8 月 8 日星期四出售了 586 股股票。该股票的均价为 225.00 美元，总价值为 131,850.00 美元。此次交易完成后，该董事直接持有公司 14,722 股股票，价值约 3,312,450 美元。此次交易的披露信息可在此处找到。过去 90 天内，内部人士共出售了 29,679 股公司股票，价值 6,716,306 美元。目前，公司股份的 0.85% 由内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several institutional investors have recently modified their holdings of the business. Sanctuary Advisors LLC purchased a new stake in Laboratory Co. of America in the second quarter worth about $2,268,000. Delphi Management Inc. MA boosted its stake in Laboratory Co. of America by 134.9% during the 2nd quarter. Delphi Management Inc. MA now owns 8,246 shares of the medical research company's stock valued at $1,678,000 after purchasing an additional 4,736 shares during the last quarter. 3Chopt Investment Partners LLC bought a new stake in shares of Laboratory Co. of America in the 2nd quarter worth $1,318,000. EP Wealth Advisors LLC raised its stake in shares of Laboratory Co. of America by 27.0% in the second quarter. EP Wealth Advisors LLC now owns 1,226 shares of the medical research company's stock worth $250,000 after purchasing an additional 261 shares during the last quarter. Finally, Brandes Investment Partners LP lifted its holdings in shares of Laboratory Co. of America by 25.3% during the second quarter. Brandes Investment Partners LP now owns 494,068 shares of the medical research company's stock valued at $100,609,000 after purchasing an additional 99,912 shares in the last quarter. 95.94% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者最近调整了他们对该公司的持股。Sanctuary Advisors LLC 在第二季度购入了 Laboratory Co. of America 的新股份，价值约 2,268,000 美元。Delphi Management Inc. MA 在第二季度将其对 Laboratory Co. of America 的持股增加了 134.9%。Delphi Management Inc. MA 现在拥有 8,246 股该医疗研究公司的股票，价值 1,678,000 美元，较上一季度增加了 4,736 股。3Chopt Investment Partners LLC 在第二季度购入了 Laboratory Co. of America 的新股份，价值 1,318,000 美元。EP Wealth Advisors LLC 在第二季度增加了其对 Laboratory Co. of America 的持股，增幅为 27.0%。EP Wealth Advisors LLC 现在拥有 1,226 股该医疗研究公司的股票，价值 250,000 美元，较上一季度增加了 261 股。最后，Brandes Investment Partners LP 在第二季度增加了其对 Laboratory Co. of America 的持股，增幅为 25.3%。Brandes Investment Partners LP 现在拥有 494,068 股该医疗研究公司的股票，价值 100,609,000 美元，较上一季度增加了 99,912 股。目前，公司股份的 95.94% 由机构投资者持有。</p>
</div><h2>Laboratory Co. of America Company Profile (Get Free Report)</h2>
<div class="lb-trans"><h2>美国实验室公司简介（获取免费报告）</h2>
</div><p>Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS).</p>
<div class="lb-trans"><p>美国实验室公司是一家生命科学公司，为医生、医院、制药公司、研究人员和患者提供重要信息，帮助他们做出明晰自信的决策。公司分为实验室公司诊断（Dx）和生物制药实验室服务（BLS）两个部分运营。</p>
</div><h2>See Also</h2>
<ul>
<li>Five stocks we like better than Laboratory Co. of America</li>
<li>What is a Dividend King?</li>
<li>Triple Witching: The Market's Quarterly Rollercoaster</li>
<li>3 Grocery Stocks That Are Proving They Are Still Essential</li>
<li>4 Stocks Set to Benefit from Recent Interest Rate Cuts</li>
<li>The How and Why of Investing in Gold Stocks</li>
<li>Autohome’s Dividend and Buyback Make It a Strong EV Play</li>
</ul>
<div class="lb-trans"><h2>参见</h2>
<ul>
<li>我们喜欢的五支股票，胜过美国实验室公司</li>
<li>什么是股息王？</li>
<li>三重巫术：市场的季度过山车</li>
<li>3 家证明仍然必不可少的杂货股</li>
<li>4 支将受益于最近降息的股票</li>
<li>投资黄金股的方法和原因</li>
<li>Autohome 的股息和回购使其成为强劲的电动汽车投资</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxI" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=LH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由市场数据和 MarketBeat 的叙事科技生成，旨在为读者提供最快速、最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><p>→ Who are Nvidia’s New Silent Partners? (From Weiss Ratings)(Ad)</p>
<div class="lb-trans"><p>→ Nvidia 的新潜在合作伙伴是谁？（来自 Weiss Ratings）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NjMy" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9632&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Laboratory Co. of America right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资美国实验室公司 1,000 美元？</h2>
</div><p>Before you consider Laboratory Co. of America, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资美国实验室公司之前，您需要听到这个消息。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Laboratory Co. of America wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街评级最高、表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已经确定了五支顶级分析师悄悄告诉客户现在购买的股票清单...而美国实验室公司不在其中。</p>
</div><p>While Laboratory Co. of America currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美国实验室公司目前在分析师中有 “中等买入” 评级，但顶级分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

实验美控（纽约证券交易所代码：LH）目标价上调至 282.00 美元